Affluent Medical SA (0JZ) Stock Price & Analysis

0 Followers

0JZ Stock Chart & Stats

€5.14€0.23(3.63%)

At close: Nov 10 5:30 PM GMT+1

Day’s Range: EUR 4.96 - EUR 5.14
52-Week Range: EUR 1.28 - EUR 7.20
Previous Close: EUR 4.96
Volume: N/A
Average Volume (3M): 17
Market Cap: EUR 313.62M
Enterprise Value: EUR 204.58M
Total Cash (Recent Filing): EUR 7.02M
Total Debt (Recent Filing): EUR 19.48M
Price to Earnings (P/E): ―
Beta: -0.04
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Diversified Clinical Pipeline

A pipeline spanning structural heart and urology gives Affluent Medical several clinical and regulatory opportunities rather than dependence on one indication. If candidates progress, this breadth can support multiple commercialization paths and reduce concentration in a single product area.

Implantable Minimally Invasive Focus

Concentration on implantable, minimally invasive devices creates a consistent technology and development focus across the portfolio. This specialization may help the company build expertise in complex procedures while advancing products for significant heart and urinary conditions.

Partnering Commercialization Optionality

The ability to commercialize directly or through partners gives Affluent Medical strategic flexibility as its devices approach approval. Partner-led routes could provide access to commercial capabilities while preserving an alternative path if the company develops products internally.

Bears Say

No Current Revenue And Widening Losses

Zero reported revenue combined with negative gross profit and widening losses shows that the company has not yet established a self-sustaining commercial model. Continued development therefore remains dependent on future product progress and eventual revenue generation.

Persistent Cash Burn

Persistent operating and free-cash-flow deficits mean reported losses are translating into substantial cash consumption rather than remaining largely non-cash. Until revenue and losses stabilize, ongoing development may require repeated access to external funding.

Deteriorating Balance-Sheet Flexibility

Higher debt alongside sharply reduced equity increases financial risk and limits balance-sheet flexibility. The resulting leverage can constrain funding choices and make it harder for Affluent Medical to absorb further development delays or continue investment without additional capital.

Affluent Medical SA News

Carvolix Reports October Share Capital and Voting Rights

Affluent Medical SA ( ($FR:CVX) ) just unveiled an update. Carvolix is a French medical technology company developing solutions for structural heart disease and stroke. Its portfolio includes artificial-intelligence- and

1w ago0JZ CVX

Carvolix Updates Share Capital and Voting Rights Structure

An announcement from Affluent Medical SA ( ($FR:CVX) ) is now available. French medtech group Carvolix, which develops AI-guided interventional mini-robots and biomimetic heart valves for structural heart disease and

1M ago0JZ CVX

Carvolix Strengthens Governance and Funding as TAVIPILOT and Kalios Advance Clinically

Affluent Medical SA ( ($FR:CVX) ) just unveiled an update. Carvolix has appointed technology investor and seasoned board member Anne Lange as chair, reinforcing its governance with new observers and

1M ago0JZ CVX

Carvolix files FDA submission for TAVIPILOT robot amid expanding U.S. TAVI market

Affluent Medical SA ( ($FR:CVX) ) just unveiled an announcement. Carvolix has filed a 510(k) application with the U.S. Food and Drug Administration for its TAVIPILOT robot, the hardware component

1M ago0JZ CVX

Carvolix updates share capital and voting rights structure

The latest announcement is out from Affluent Medical SA ( ($FR:CVX) ). Carvolix has disclosed updated figures for its share capital and voting rights as of 31 August 2026, reporting

2M ago0JZ CVX

Carvolix Files for CE Marking to Launch TAVIPILOT AI TAVI Software in Europe

The latest update is out from Affluent Medical SA ( ($FR:CVX) ). Carvolix has submitted the regulatory dossier for its TAVIPILOT AI software to obtain EU CE marking, aiming to

2M ago0JZ CVX

Carvolix and Truffle Capital Launch Franco-Saudi SAF-MD Program and Plan Saudi MedTech Hub

Affluent Medical SA ( ($FR:CVX) ) has issued an announcement. Truffle Capital and its portfolio company Carvolix SA, together with Carvolix Saudi LLC, have launched the SAF-MD Saudi–French Medical Exchange

2M ago0JZ CVX

Carvolix Secures €30 Million Structured Debt to Fund AI-Driven Cardio Robotics Push

Affluent Medical SA ( ($FR:CVX) ) has shared an announcement. Carvolix has secured up to €30 million in structured debt financing from Claret Capital Partners, comprising senior secured convertible and

3M ago0JZ CVX

Carvolix Updates Market on Share Capital and Voting Rights Structure

Affluent Medical SA ( ($FR:CVX) ) has provided an update. Carvolix has reported that its share capital as of 31 July 2026 comprises 62,275,177 shares, corresponding to a theoretical total

3M ago0JZ CVX

ODDO BHF Launches Outperformance Coverage on Carvolix, Signaling Strong Upside Potential

Affluent Medical SA ( ($FR:CVX) ) has shared an announcement. Carvolix has gained fresh attention in the equity markets after ODDO BHF initiated coverage of the stock with an Outperformance

3M ago0JZ CVX

0JZ FAQ

What was Affluent Medical SA’s price range in the past 12 months?

Affluent Medical SA lowest stock price was €1.28 and its highest was €7.20 in the past 12 months.

What is Affluent Medical SA’s market cap?

Affluent Medical SA’s market cap is €313.62M.

When is Affluent Medical SA’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Affluent Medical SA’s earnings last quarter?

Affluent Medical SA released its earnings results on Sep 30, 2026. The company reported -€0.25 earnings per share for the quarter.

Is Affluent Medical SA overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Affluent Medical SA pay dividends?

Affluent Medical SA does not currently pay dividends.

What is Affluent Medical SA’s EPS estimate?

Affluent Medical SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Affluent Medical SA have?

Affluent Medical SA has 62,278,385 shares outstanding.

What happened to Affluent Medical SA’s price movement after its last earnings report?

Affluent Medical SA reported an EPS of -€0.25 in its last earnings report. Following the earnings report the stock price went up 3.597%.

Which hedge fund is a major shareholder of Affluent Medical SA?

Currently, no hedge funds are holding shares in DE:0JZ

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description